Xcellerant Ventures

Latest fund size

$7M

Announced

April 3, 2025

Global HQ

United States

Members only

Check size

$250K - $1M

Members only

Stage focus

Pre-Seed, Seed, Series A

Members only

Regions of investment

North America

Members only

About

Xcellerant Ventures is a Scottsdale, Arizona–based venture capital firm specializing in early-stage investments within the healthtech, medtech, and biotech sectors. The firm is dedicated to funding technologies that enhance healthcare quality, efficiency, access, and delivery while reducing costs. Xcellerant emphasizes a "people first" philosophy, providing capital and strategic guidance to empower entrepreneurs in transforming healthcare.

Contact info

Members only

Names, roles, emails and LinkedIn profiles for the team, plus the fund's website.

Investment focus

Xcellerant Ventures targets early-stage companies in the healthtech, medtech, and biotech industries. The firm seeks dynamic founders who are humble, open to advice, and driven to effect positive change. Xcellerant prioritizes companies that have cleared regulatory hurdles, generate revenue, and demonstrate a clear path to rapid growth.

Members only

What the fund looks for in founders and which sectors it backs.

Fund

In April 2025, Xcellerant Ventures raised $7 million in partnership with AZ Venture Capital Inc. to invest in Arizona-based healthtech startups. This funding aims to bolster Arizona's position as a hub for healthcare innovation.

Members only

Fund size, LPs and track record.

Other information

Leadership‍

The firm is led by Founding Partners John Shufeldt, MD; Douglas Sylvester, JD; and Christopher Yoo, Ph.D. The team also includes Principal Michael Shufeldt, MBA, and Associate & Controller TJ Kline.

‍

Investment Strategy‍

Xcellerant focuses on early-stage investments in companies that address real-world healthcare problems through emerging technologies. The firm seeks startups with expedited paths to financial growth and emphasizes partnerships that improve healthcare quality, accessibility, efficiency, and affordability.

‍

Notable Investments‍

Xcellerant's portfolio includes companies such as CRISPR QC, DeepLook Medical, Anuncia Medical, Lenoss Medical, and TruLite Health.

‍

Notable Exits‍

The firm has achieved successful exits, including Rivia Health.

Members only

Leadership, investment strategy, notable investments and exits.

Unlock this fund's full profile

✓ Emails and LinkedIn for the team

✓ Check size, stage focus and regions of investment

✓ LPs, notable investments and exits

✓ Search and filters across 700+ funds

Unlock this fund and 700+ more

From $14/month, billed yearly. Cancel any time.

Read the newsletter that top VCs and founders keep in their inbox.

Join the weekly newsletter